TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Dyne Therapeutics Announces Pricing of Upsized $350.0 Million Public Offering of Common Stock

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Dyne Therapeutics
Dyne Therapeutics Announces Pricing of Upsized $350.0 Million Public Offering of Common Stock

Dyne Therapeutics plans to raise $350 million through a public offering of 18,980,478 common stock shares at $18.44 per share, with potential additional shares through underwriter option.

Insights
GOOGL   neutral

Briefly mentioned as using AMD's chips, with no specific performance details


DYN   neutral

The company is raising capital through a standard public stock offering, which indicates a strategic financial move to fund ongoing research and development without immediate positive or negative implications